Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY14 | Q15391 | 2/20 | 0.42 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.38 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.38 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.38 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.38 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL442715 | 0.84 | P2RY14 (0.48) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL7524816 | 0.80 | SLC28A1 (0.47) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL8970268 | 0.79 | P2RY14 (0.46) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL8678169 | 0.78 | P2RY14 (0.41) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL8538694 | 0.77 | P2RY14 (0.44) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL6832098 | 0.77 | P2RY14 (0.44) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL8210384 | 0.77 | P2RY14 (0.44) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL9157699 | 0.75 | SLC28A1 (0.53) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL21475705 | 0.73 | P2RY14 (0.43) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL442714 | 0.73 | SLC28A1 (0.43) | P2RY14SLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5854410-A | Oligonucleoside cleavage compounds and therapies | GENTA INCORPORATED (US) | 1998-12-29 | — | — | US | disclosed |
| WO-1995026733-A1 | OLIGONUCLEOSIDE CLEAVAGE COMPOUNDS AND THERAPIES | GENTA INCORPORATED (US) | 1995-10-12 | — | — | WO | disclosed |